First Time Loading...
H

Healthcare Co Ltd
SSE:603313

Watchlist Manager
Healthcare Co Ltd
SSE:603313
Watchlist
Price: 8.63 CNY -0.92% Market Closed
Updated: May 7, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

9.7B
+2%
Assets
Growth Rates:
1 Year
+3%
3 Years
+50%
5 Years
+244%
7 Years
+376%
10 Years
-
6.6B
+3%
Liabilities
Growth Rates:
1 Year
+3%
3 Years
+80%
5 Years
+455%
7 Years
+1 426%
10 Years
-
3.1B
-0.7%
Equity
Growth Rates:
1 Year
+4%
3 Years
+11%
5 Years
+91%
7 Years
+94%
10 Years
-

Balance Sheet Decomposition
Healthcare Co Ltd

9.7B
Assets
6.6B
Liabilities
9.7B
Assets
6.6B
Liabilities
Current Assets 4B
Cash & Short-Term Investments 493.1m
Receivables 1.7B
Other Current Assets 1.8B
Non-Current Assets 5.7B
Long-Term Investments 202.2m
PP&E 4B
Intangibles 453.3m
Other Non-Current Assets 987.2m
Current Liabilities 4.3B
Accounts Payable 1.5B
Accrued Liabilities 103.3m
Short-Term Debt 1.6B
Other Current Liabilities 1.1B
Non-Current Liabilities 2.3B
Long-Term Debt 1.5B
Other Non-Current Liabilities 717.3m

Balance Sheet
Healthcare Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
57
71
96
602
603
1 039
805
1 061
777
453
Cash
0
0
0
1
1
0
1
0
777
453
Cash Equivalents
57
71
96
601
602
1 039
804
1 061
0
0
Short-Term Investments
3
0
0
0
0
0
0
39
61
22
Total Receivables
162
147
198
241
434
626
975
1 233
1 291
1 472
Accounts Receivables
131
125
179
215
387
567
791
997
1 125
1 342
Other Receivables
32
22
19
26
47
59
184
236
165
131
Inventory
149
171
181
225
326
368
742
1 368
1 939
1 730
Other Current Assets
5
24
27
344
59
69
87
149
355
225
Total Current Assets
377
413
502
1 412
1 421
2 102
2 608
3 850
4 423
3 902
PP&E Net
172
225
371
483
585
897
1 490
2 200
3 684
3 990
PP&E Gross
0
0
371
483
585
897
1 490
2 200
3 684
3 990
Accumulated Depreciation
0
0
63
88
140
183
246
534
833
1 276
Intangible Assets
36
35
76
75
123
130
178
180
197
171
Goodwill
0
0
0
0
60
60
91
321
321
288
Note Receivable
0
0
0
0
0
0
0
26
0
0
Long-Term Investments
0
0
1
8
108
162
200
254
189
234
Other Long-Term Assets
19
66
43
11
12
25
52
245
385
491
Other Assets
0
0
0
0
60
60
91
321
321
288
Total Assets
604
N/A
739
+22%
991
+34%
1 988
+101%
2 309
+16%
3 376
+46%
4 620
+37%
7 076
+53%
9 199
+30%
9 076
-1%
Liabilities
Accounts Payable
98
98
103
140
268
331
486
934
1 493
1 272
Accrued Liabilities
9
11
17
19
27
28
54
125
144
106
Short-Term Debt
99
102
124
65
354
674
1 017
1 112
1 633
1 857
Current Portion of Long-Term Debt
0
2
6
1
61
2
301
219
598
488
Other Current Liabilities
18
15
23
22
32
77
161
293
323
201
Total Current Liabilities
223
227
272
248
741
1 112
2 019
2 683
4 190
3 924
Long-Term Debt
0
0
55
57
3
363
181
607
1 850
1 910
Deferred Income Tax
1
0
0
0
0
1
8
43
48
53
Minority Interest
4
2
3
1
14
31
70
137
87
83
Other Liabilities
0
6
18
18
19
15
9
49
117
127
Total Liabilities
227
N/A
235
+3%
347
+48%
324
-7%
777
+140%
1 521
+96%
2 286
+50%
3 519
+54%
6 292
+79%
6 098
-3%
Equity
Common Stock
180
180
180
240
240
240
334
374
487
485
Retained Earnings
109
240
380
535
403
589
865
1 243
836
877
Additional Paid In Capital
87
87
87
890
890
890
1 111
1 981
1 815
1 791
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
65
71
Treasury Stock
0
0
0
0
0
0
16
18
12
0
Other Equity
0
2
3
2
2
135
41
24
154
105
Total Equity
376
N/A
505
+34%
644
+28%
1 664
+158%
1 531
-8%
1 855
+21%
2 334
+26%
3 557
+52%
2 907
-18%
2 978
+2%
Total Liabilities & Equity
604
N/A
739
+22%
991
+34%
1 988
+101%
2 309
+16%
3 376
+46%
4 620
+37%
7 076
+53%
9 199
+30%
9 076
-1%
Shares Outstanding
Common Shares Outstanding
234
234
234
312
312
312
332
372
485
485

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.